UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Lilly bulking up on weight-loss drugs, scrutiny of a 340B contractor, and more
Stat News|2/13/2026
P
pharmalittle
21 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
11
Activity (Last 30 Days)
1
1
1
1
1
1
1
1
1
1
1
2026-01-262026-02-13
Top Publishers
Stat News11 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA rejecting a rare disease drug, a warning to a Hims compounding pharmacy and more
Stat News|2/10/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and more
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Super Bowl drug ads, an FTC deal with Express Scripts, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and more
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and more
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and more
Stat News|1/26/2026